Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2008
11/18/2008CA2440399C Epitope testing using hla
11/18/2008CA2439500C Drug delivery system for hydrophobic drugs
11/18/2008CA2423659C Antiviral composition and treatment method
11/18/2008CA2416147C Dermal application system for aminolevulinic acid
11/18/2008CA2415840C Pharmaceutical pellets comprising tamsulosin and a process for making the same
11/18/2008CA2406846C Pharmacotherapeutic process and composition for central nervous system disorders
11/18/2008CA2402652C Viscoelastics for use in middle ear surgery
11/18/2008CA2397537C External plaster containing 4-biphenylyl acetic acid
11/18/2008CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2376202C Novel preparation and administration form comprising an acid-labile active compound
11/18/2008CA2368625C Solubilizing aids in powder form for solid pharmaceutical presentation forms
11/18/2008CA2359640C Topical sprays
11/18/2008CA2358054C Cyanocobalamin (vitamin b12) treatment in allergic disease
11/18/2008CA2352430C New pharmaceutical composition and the process for its preparation
11/18/2008CA2342587C Long term drug-sustained release preparation
11/18/2008CA2341366C Micronised pharmaceutical compositions
11/18/2008CA2340417C Methods for forming regional tissue adherent barriers and drug delivery systems
11/18/2008CA2339190C Compressed compositions comprising clarified xanthan gum
11/18/2008CA2336945C Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
11/18/2008CA2335686C Particulate acellular tissue matrix
11/18/2008CA2333442C Spray composition
11/18/2008CA2329167C Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
11/18/2008CA2326809C Solid, quick dissolving cetirizine formulations
11/18/2008CA2316539C Sustained-release pharmaceutical composition
11/18/2008CA2314326C Transdermal therapeutic device and method with capsaicin and capsaicin analogs
11/18/2008CA2301725C Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
11/18/2008CA2301646C Pharmaceutical suspension comprising nevirapine hemihydrate
11/18/2008CA2290315C Method for producing dispersible sterol and stanol compounds
11/18/2008CA2285430C Calcium phosphate microcarriers and microspheres
11/18/2008CA2281614C Monomers derived from hydroxy acids and polymers prepared therefrom
11/18/2008CA2281420C Preparation of pharmaceutically-active granules
11/18/2008CA2277791C Oxcarbazepine film-coated tablets
11/18/2008CA2263924C Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator
11/18/2008CA2259764C Pharmaceutical compositions containing mupirocin
11/18/2008CA2259430C Water miscible erythromycin solutions
11/18/2008CA2247115C Inhibition of selectin binding
11/18/2008CA2241941C Therapeutic agent containing .omega.-feline interferon for treating feline aids virus infections and feline atopic dermatitis
11/18/2008CA2205112C Method and composition for treating mammalian diseases caused by inflammatory response
11/13/2008WO2008137917A1 Method of treating bacterial infections with antibacterial formulations
11/13/2008WO2008137826A2 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
11/13/2008WO2008137778A2 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
11/13/2008WO2008137747A1 Nanoemulsion therapeutic compositions and methods of using the same
11/13/2008WO2008137717A1 Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
11/13/2008WO2008137632A1 Antimicrobial compositions, products, and methods of use
11/13/2008WO2008137496A1 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
11/13/2008WO2008137420A1 Honokiol analogs and their use in treating cancers
11/13/2008WO2008137164A1 Edible thin film strips and process for making
11/13/2008WO2008137066A1 Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
11/13/2008WO2008137054A2 Composition for transmucosal delivery of polypeptides
11/13/2008WO2008136843A1 Novel pharmaceutical composition
11/13/2008WO2008136707A1 Ophthalmological gel and a method for the use thereof
11/13/2008WO2008136705A2 Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
11/13/2008WO2008136699A1 Transdermal patch with microcapsules and a method for the production thereof
11/13/2008WO2008136636A1 Composition for fast disintegrating tablet containing herbal extract and its preparation method
11/13/2008WO2008136392A1 Preparation for oral administration
11/13/2008WO2008136380A1 Method for production of tablet
11/13/2008WO2008136034A2 Ophthalmic compositions for the treatment of ocular hypertension and glaucoma
11/13/2008WO2008136016A1 A stable controlled release oral solid dosage form composition and a process thereof
11/13/2008WO2008135855A2 Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
11/13/2008WO2008135852A2 Pharmaceutical compositions comprising nanoparticles and casein
11/13/2008WO2008135829A2 Nanoparticles comprising cox-2 inhibitors and a non-ionizable polymer
11/13/2008WO2008135828A2 Nanoparticles comprising a drug, ethylcellulose, and a bile salt
11/13/2008WO2008135792A1 Pm00104 compound for use in cancer therapy
11/13/2008WO2008135601A2 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
11/13/2008WO2008135562A1 Self-precipitating pharmaceutical formulations for the modified release of active principle
11/13/2008WO2008135561A1 Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutical formulations containing these particles
11/13/2008WO2008135527A2 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
11/13/2008WO2008135500A1 High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant
11/13/2008WO2008135460A2 Aqueous aerosol preparations containing therapeutically active micro-organisms or parts of micro-organisms and method for producing corresponding aerosols
11/13/2008WO2008135361A2 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof
11/13/2008WO2008135297A1 Method for producing a granular material from water-soluble vitamins
11/13/2008WO2008135283A1 Transdermal therapeutic system containing at least two opioids
11/13/2008WO2008135263A1 Transdermal therapeutic system comprising remifentanil
11/13/2008WO2008135203A1 Slow release misoprostol for obstetric and/or gynaecological applications
11/13/2008WO2008135090A1 Solid dosage forms comprising an enteric coating with accelerated drug release
11/13/2008WO2008134912A1 Means for the application of active substances in the ear canal of a patient
11/13/2008WO2008134817A1 Composite carriers for dry powder inhalation therapy
11/13/2008WO2008113901A3 Composition with controlled release of levetiracetam and method for preparing same
11/13/2008WO2008107746A3 Tablet comprising microorganisms and a combination of excipients and the manufacture process thereof
11/13/2008WO2008097529B1 Tissue compatible material and methods using same
11/13/2008WO2008067049A3 Particles for cell targeting
11/13/2008WO2008062429A3 Particles for delivery of active ingredients, process of making and compositions thereof
11/13/2008WO2008060575A3 Drug delivery system and method
11/13/2008WO2008060506A3 Adhesive-forming composition and blend of adhesives obtained therefrom
11/13/2008WO2008057266A3 Dry granulation binders, products, and use thereof
11/13/2008WO2008046041A3 Dissolving strip for oral mucosa as a systemic drug delivery route
11/13/2008WO2008043974A3 Two-compartment skincare products comprising ivermectin, and uses thereof
11/13/2008WO2008030807A3 Phosphatidylethanolamine derivative and liposome containing the same
11/13/2008WO2008024422A3 Methods and compositions for decontamination and treatment of disease or injury
11/13/2008WO2008022189A3 Administration of high potency platinum compound formulations by inhalation
11/13/2008WO2008019146A3 Aqueous dronabinol formulations
11/13/2008WO2008014423A3 An elastomeric flexible article with absorbant polymer and manufacturing method
11/13/2008WO2008011596A3 Hydrophilic abuse deterrent delivery system
11/13/2008WO2008011595A3 Hydrophobic abuse deterrent delivery system
11/13/2008WO2008008483A3 Dendrimer based compositions and methods of using the same
11/13/2008WO2008002529A3 Orally disintegrating layered compositions
11/13/2008WO2007121188A3 Compositions and methods of using r(+) pramipexole
11/13/2008WO2007109303A3 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
11/13/2008WO2007014497A8 A composition comprising silver nanoparticles and the use thereof
1 ... 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 ... 2991